Search Results
Jun 02, 2026, 08:00 ET Converge Bio Secures $2.5M Grant to expand its fast-track AI gene discovery capabilities from pharma to growing climate-resilient crops
systems, leading to a U.S.-licensed patent and a scientific publication in collaboration with Nobel laureate Jennifer Doudna. CSO Iddo Weiner holds a PhD in Bioinformatics and Biomedical Engineering, and has led the development of two drug programs through positive Phase 2 clinical readouts. CTO Oded Kalev
More news about: Converge Bio
Jun 02, 2026, 07:00 ET NYU LANGONE HEALTH ANNOUNCES PLANS FOR A STATE-OF-THE-ART ACADEMIC MEDICAL CENTER IN MELVILLE
construction and beyond."This is one of the most ambitious and exciting projects ever undertaken by NYU Langone," said Alec C. Kimmelman, MD, PhD, dean and CEO of NYU Langone. "The benefits to Long Island—a community I grew up in, and one that our institution cares deeply about—will allow us to
More news about: NYU Langone Health System
Jun 02, 2026, 06:30 ET Health Optimization Medicine and Practice to Host 2026 Conference in Chicago, Bringing Leading Clinicians and Health Optimizers to The Drake Hotel
psychedelic-assisted therapy and the clinical application of health optimization protocols.Confirmed speakers include Dominic D'Agostino, PhD, tenured associate professor at the University of South Florida Morsani College of Medicine; JJ Virgin, triple-board certified nutrition expert
More news about: Troscriptions
Jun 02, 2026, 00:00 ET Genomics Launches the Mystra AI Platform, Adopted by Industry Giants and Up-and-Coming Biotechs
of drug discovery," said Rowland Illing, Chief Medical Officer at Amazon Web Services. "In real time, you can do the work of an entire PhD in minutes".Mishal Patel, Global Vice President of AI and Digital Innovation, R&D, at Novo Nordisk, said: "Genetics is one of those
More news about: Genomics Limited
Jun 01, 2026, 18:16 ET /C O R R E C T I O N -- Ranok Therapeutics/
mutation, providing strong biological validation of RNK08954 potent target engagement and mechanism of action.Professor Zhengbo Song, MD, PhD, Lead Investigator, Zhejiang Cancer Hospital commented "These interim data are highly encouraging for patients with advanced KRAS G12D-mutated NSCLC
More news about: Ranok Therapeutics
Jun 01, 2026, 11:11 ET Conscientia Health Emerges as a Pioneer in Clinician-Driven AI for Mental Healthcare
Dr. Simbiat Adighije, PMHNP, MBBS, PhD, founder and CEO of Conscientia Health. "Our AI is not autonomous — it is clinician-trained, clinician-approved, and clinician-supervised at every
More news about: Conscientia Health
Jun 01, 2026, 10:04 ET Made Scientific Selected as Manufacturer for Columbia University's Autologous and Allogeneic NOVAKnee Program - a First-in-Class Living Biologic Total Knee Replacement
change how we approach joint replacement, and a manufacturing partner with deep cell therapy expertise is essential to that goal," said Clark Hung, PhD, Vice Chair and Professor of Biomedical Engineering at Columbia University. "We look forward to working with Made Scientific as we advance NOVAKnee-L
More news about: Made Scientific, Inc.
Jun 01, 2026, 09:04 ET Healthcare Loses People Quietly: HabitNu Launches FATHOM™, Introducing Persistence Intelligence™ for Healthcare
from care."We've spent years studying what separates the people who stay engaged from the people who quietly drift away," said Sindhu Rajan, PhD, Chief Executive Officer and Co-Founder of HabitNu. "FATHOM helps organizations see those patterns earlier and gives them an opportunity to act before
More news about: HabitNu
Jun 01, 2026, 09:01 ET Veritas Aortic Solutions, an inQB8 Spinout, Raises $12M to Advance Non-Surgical Treatment of Aortic Root and Ascending Aortic Diseases
Martinson (former Medtronic CoreValve executive and former CEO of ACOVA Integrated Health), Judd Nordquist (CEO of Ibis Scientific), and Nirdesh Gupta PhD (Managing Partner of Cedars-Sinai Intellectual Property Company (CSIPCo)), joined Veritas and inQB8 co-founders, Arshad Quadri, MD and J. Brent Ratz,
More news about: Veritas Aortic Solutions
Jun 01, 2026, 09:00 ET Oshi Health Publishes Peer-Reviewed Study of 11,000+ Patients Validating Virtual Multidisciplinary GI Care at Scale
"Virtual Multidisciplinary Gastrointestinal Care for Adults with Gastrointestinal (GI) Needs: A Retrospective Cohort Study," was authored by Grace Wang, PhD, MPH (Oshi Health); William D. Chey, MD (University of Michigan); Sanskriti Varma, MD (Massachusetts General Hospital, Harvard Medical School); and Sameer
More news about: Oshi Health
Jun 01, 2026, 08:30 ET Why Level Setting around Site Technology May Be The Most Overlooked Step in Clinical Trial Planning, Upcoming Webinar Hosted by Xtalks
for the Study of Drug Development; Deena Bernstein, Vice President of Account Development, Transformative Pharmaceutical Solutions (TPS); Jill Bell, PhD, Chief Scientific Officer,
More news about: Xtalks
Jun 01, 2026, 08:30 ET STAR Network Foundation Named Sponsor of Global Summit 2026: Fostering Hope for Children
Papal General Audience with Pope Leo XIVH.E. Dr. Fatima Maada Bio, First Lady of Sierra LeoneRima Salah, PhD, Chair, Early Childhood Peace ConsortiumEdgar Sandoval, Sr., President and CEO, World Vision U.S.The Light of Love
More news about: STAR Network
Jun 01, 2026, 08:11 ET Cancer Vaccine Sustains 49 Percent Melanoma Reduction After 5 Years
were lead investigator Adnan Khattak, MD, PhD, at Hollywood Private Hospital and Edith Cowan University, in Perth, Australia; co-investigators Matteo Carlino, MD, PhD, and Georgina Long, MD, PhD, at the University of Sydney in Australia; Tarek Meniawy, PhD, at Saint John of God Hospital Subiaco Hospital
More news about: NYU Langone Health System
Jun 01, 2026, 08:09 ET Sonire Therapeutics Completes Enrollment in SUNRISE-I Randomized Controlled Trial of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
pancreatic cancer treatment and highlights the growing clinical interest in advancing new therapeutic options for patients," said Pejman Ghanouni, MD, PhD, Principal Investigator of Sonire Therapeutics' U.S.-based SUNRISE-II study. Ghanouni is also a Professor of Radiology at Stanford Medicine.By
More news about: Sonire Therapeutics
Jun 01, 2026, 08:05 ET The Back Pain Myths Patients Still Believe. And What Science Says Instead
Christine Goertz, DC, PhD, author of the forthcoming book Take Your Back Back: Whole Health Healing for Low Back Pain. "Unfortunately, patients are often overwhelmed by
More news about: Dr. Christine Goertz
Jun 01, 2026, 06:30 ET Skyhawk Therapeutics Announces Twelve-Month Interim Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease
the extraordinary power of the ability to modulate RNA splicing with a small molecule, offering a therapy to patients worldwide," said Phillip Sharp, PhD, Founding Member of Skyhawk's Scientific Advisory Board and Nobel Prize Laureate for his groundbreaking work on RNA splicing. "The RNA revolution continues
More news about: Skyhawk Therapeutics
Jun 01, 2026, 06:30 ET Skyhawk Therapeutics Announces Twelve-Month Interim Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease
the extraordinary power of the ability to modulate RNA splicing with a small molecule, offering a therapy to patients worldwide," said Phillip Sharp, PhD, Founding Member of Skyhawk's Scientific Advisory Board and Nobel Prize Laureate for his groundbreaking work on RNA splicing. "The RNA revolution continues
More news about: Skyhawk Therapeutics
Jun 01, 2026, 04:00 ET Equifax partners with Poland's leading credit bureau to expand client access to identity and fraud solutions
with the advanced tools they need to protect their customers and support more confident, secure digital interactions."Mariusz Cholewa, PhD, President of the Management Board at BIK, said: "This partnership reflects a clear reality: effective fraud prevention increasingly depends on
More news about: BIURO INFORMACJI KREDYTOWEJ S.A. (BIK)
Jun 01, 2026, 04:00 ET Equifax partners with Poland's leading credit bureau to expand client access to identity and fraud solutions
with the advanced tools they need to protect their customers and support more confident, secure digital interactions."Mariusz Cholewa, PhD, President of the Management Board at BIK, said: "This partnership reflects a clear reality: effective fraud prevention increasingly
More news about: BIURO INFORMACJI KREDYTOWEJ S.A. (BIK)
Jun 01, 2026, 04:00 ET Equifax geht eine Partnerschaft mit Polens führender Kreditauskunftei ein, um seinen Kunden einen besseren Zugang zu Lösungen im Bereich Identitäts- und Betrugsschutz zu ermöglichen
die sie benötigen, um ihre Kunden zu schützen und vertrauensvollere, sicherere digitale Interaktionen zu ermöglichen."Mariusz Cholewa, PhD, Vorstandsvorsitzender von BIK, sagte: „Diese Partnerschaft spiegelt eine klare Tatsache wider: Eine wirksame Betrugsbekämpfung hängt zunehmend
More news about: BIURO INFORMACJI KREDYTOWEJ S.A. (BIK)
Jun 01, 2026, 04:00 ET Equifax se asocia con la principal agencia de crédito de Polonia
herramientas avanzadas que necesitan para proteger a sus clientes y fomentar interacciones digitales más seguras y confiables".Mariusz Cholewa, PhD, presidente del Consejo de Administración en BIK, comentó: "Esta alianza refleja una clara realidad: la prevención eficaz del fraude depende
More news about: BIURO INFORMACJI KREDYTOWEJ S.A. (BIK)
May 31, 2026, 23:30 ET LaennecAI launches Zorgm Pro: A free medical education answer engine built by doctors, for doctors
global evidence and the relevant local clinical context. "Medical evidence is vast, but volume alone is not enough," said Dr Arathy Varghese, PhD, Co-Founder of LaennecAI. "Zorgm Pro is designed to organise trusted guidelines, medicines information, international references, and peer-reviewed medical
More news about: LaennecAI
May 31, 2026, 23:30 ET LaennecAI ने Zorgm Pro लॉन्च किया: डॉक्टरों की आवश्यकताओं को ध्यान में रखकर डॉक्टरों द्वारा तैयार किया गया एक निःशुल्क चिकित्सा-शिक्षा उत्तर इंजन
स्रोतों का उपयोग करता है जो वैश्विक शोध और स्थानीय चिकित्सा परिस्थितियों दोनों को ध्यान में रखते हैं। LaennecAI की सह-संस्थापक डॉ. आरती वर्गीज़, PhD ने कहा, "चिकित्सीय साक्ष्यों का दायरा अत्यंत व्यापक है, लेकिन केवल उनकी मात्रा ही पर्याप्त नहीं है।" उन्होंने कहा, "Zorgm Pro की अभिकल्पना विश्वसनीय
More news about: LaennecAI
May 30, 2026, 14:30 ET Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years
responders now followed for at least 36 months, 83% with ongoing response, including 5 patients who are surgery-free beyond 4 years," said Helen Sabzevari, PhD, President and CEO of Precigen. "For adults living with RRP, durability matters. These results continue to show that PAPZIMEOS provides sustained complete
More news about: Precigen, Inc.
May 30, 2026, 08:05 ET ROADS Phase 3 Clinical Trial Data Presented at ASCO26 Show GammaTile® Provides Superior Tumor Control Leading to Patients Living Longer Without Recurrence Compared to Standard of Care in Newly Diagnosed Operable Brain Metastases
about the ROADS data?The multicenter ROADS trial was co-led by Jeffrey Weinberg, MD, professor of Neurosurgery, and Thomas H. Beckham, MD, PhD, assistant professor of CNS Radiation Oncology at The University of Texas MD Anderson Cancer Center."Surgery is the primary treatment for operable
More news about: GT Medical Technologies